Status:
COMPLETED
Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection
Lead Sponsor:
Eurasian Association of Therapists
Conditions:
COVID-19
Chronic Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Depersonalized multi-centered registry initiated to analyze dynamics of non-infectious diseases after SARS-CoV-2 infection in population of Eurasian adult patients.
Detailed Description
Assessment of hospital course and health status during 3, 6, 12 months after discharge in COVID-19 patients in cohorts with comorbidities and without comorbidities. Evaluation of comorbidity impact to...
Eligibility Criteria
Inclusion
- Suspected or confirmed COVID-19
Exclusion
- Age under 18 years.
- Refusal to be involved in study;
Key Trial Info
Start Date :
February 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2023
Estimated Enrollment :
3554 Patients enrolled
Trial Details
Trial ID
NCT05226416
Start Date
February 21 2022
End Date
April 21 2023
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eurasian Association of Therapists
Moscow, Russia, 101000